Talazoparib beyond BRCA: A phase II trial of talazoparib monotherapy in BRCA1 and BRCA2 wild-type patients with advanced HER2-negative breast cancer or other solid tumors with a mutation in homologous recombination (HR) pathway genes.

被引：43

作者：

Gruber, Joshua James

Afghahi, Anosheh

Hatton, Alyssa

Scott, Danika

McMillan, Alex

Ford, James M.

Telli, Melinda L.

机构：

[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[2] Univ Colorado, Sch Med, Aurora, CO USA

[3] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA

来源：

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.3006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3006

引用

页数：1